CD19-antilichaam [2E2B6B10]

The CD19 antigen (95 kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation.

930

P15391

P15391

Human

Ni-NTA purified recombinant human CD19 expressed in E. Coli strain M15.

2E2B6B10

Unconjugated

Primary Antibodies

Immunology

Antibody is purified by protein A affinity chromatography.

Batch dependent

Purified antibody in PBS containing 0.03% sodium azide.

None

Blue Ice

CD19 monoclonal antibody can be stored at -20˚ C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG2a

CD19

CD19 molecule

Homo sapiens

Rie, M.A. de, J. of Immunol. Methods, 1987. 102: 187.

Rie, M.A. de, Leukaemia Research, 1988. 12: 135.

B-lymphocyte surface antigen B4B4, CVID3

WB, IHC

160332376